X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (41276) 41276
Publication (2248) 2248
Newsletter (534) 534
Book Review (445) 445
Book Chapter (198) 198
Magazine Article (140) 140
Dissertation (81) 81
Conference Proceeding (61) 61
Book / eBook (25) 25
Newspaper Article (17) 17
Reference (12) 12
Web Resource (11) 11
Trade Publication Article (10) 10
Paper (5) 5
Data Set (4) 4
Government Document (2) 2
Transcript (2) 2
Journal / eJournal (1) 1
Streaming Video (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (27834) 27834
angiotensin-converting enzyme inhibitors - therapeutic use (18319) 18319
male (17439) 17439
female (12878) 12878
animals (11276) 11276
middle aged (9484) 9484
angiotensin-converting enzyme inhibitors - pharmacology (8766) 8766
index medicus (8569) 8569
hypertension - drug therapy (8154) 8154
aged (8079) 8079
hypertension (6738) 6738
rats (6214) 6214
adult (6069) 6069
cardiac & cardiovascular systems (5759) 5759
blood pressure - drug effects (5735) 5735
angiotensin-converting enzyme inhibitors (5131) 5131
pharmacology & pharmacy (5015) 5015
angiotensin-converting enzyme (4669) 4669
antihypertensive agents - therapeutic use (4614) 4614
angiotensin (4515) 4515
heart failure - drug therapy (4158) 4158
peripheral vascular disease (4089) 4089
angiotensin-converting enzyme inhibitors - adverse effects (3974) 3974
treatment outcome (3823) 3823
adrenergic beta-antagonists - therapeutic use (3795) 3795
risk factors (3671) 3671
angiotensin-converting enzyme inhibitors - administration & dosage (3669) 3669
drug therapy, combination (3534) 3534
captopril (3394) 3394
ace inhibitors (3323) 3323
renin-angiotensin system - drug effects (3111) 3111
hypertension - physiopathology (3108) 3108
mortality (3074) 3074
medicine, general & internal (3060) 3060
blood-pressure (2954) 2954
heart failure (2931) 2931
angiotensin converting enzyme (2865) 2865
enalapril (2570) 2570
blood pressure (2567) 2567
time factors (2527) 2527
calcium channel blockers - therapeutic use (2513) 2513
enzymes (2450) 2450
urology & nephrology (2359) 2359
renin-angiotensin system (2269) 2269
diuretics - therapeutic use (2229) 2229
captopril - pharmacology (2164) 2164
angiotensin receptor antagonists (2093) 2093
hypertension - complications (2080) 2080
aged, 80 and over (2054) 2054
angiotensin ii type 1 receptor blockers - therapeutic use (1970) 1970
double-blind method (1959) 1959
research (1877) 1877
dose-response relationship, drug (1845) 1845
drug therapy (1831) 1831
myocardial-infarction (1769) 1769
peptidyl-dipeptidase a - metabolism (1757) 1757
enalapril - therapeutic use (1748) 1748
antihypertensive agents - pharmacology (1725) 1725
heart failure - physiopathology (1676) 1676
follow-up studies (1672) 1672
therapy (1578) 1578
renin-angiotensin system - physiology (1576) 1576
disease (1556) 1556
care and treatment (1549) 1549
retrospective studies (1532) 1532
clinical trials as topic (1517) 1517
randomized controlled trials as topic (1517) 1517
captopril - therapeutic use (1511) 1511
enzyme inhibitors (1506) 1506
prospective studies (1505) 1505
bradykinin (1502) 1502
hemodynamics - drug effects (1494) 1494
angiotensin converting enzyme inhibitors (1485) 1485
angiotensin-converting enzyme inhibitor (1484) 1484
heart-failure (1474) 1474
angiotensin ii (1470) 1470
prognosis (1468) 1468
analysis (1461) 1461
risk (1422) 1422
diabetes (1374) 1374
myocardial infarction - drug therapy (1373) 1373
kidney - drug effects (1359) 1359
rats, sprague-dawley (1358) 1358
enalapril - pharmacology (1327) 1327
rats, wistar (1305) 1305
health aspects (1303) 1303
angiotensin receptor antagonists - therapeutic use (1299) 1299
biochemistry & molecular biology (1262) 1262
rats, inbred shr (1250) 1250
inhibitors (1248) 1248
system (1244) 1244
medicine & public health (1240) 1240
physiology (1240) 1240
renin - blood (1240) 1240
mice (1233) 1233
diuretics (1213) 1213
physiological aspects (1183) 1183
prevention (1177) 1177
adolescent (1172) 1172
chronic disease (1161) 1161
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (37215) 37215
German (1006) 1006
French (746) 746
Japanese (728) 728
Russian (686) 686
Spanish (387) 387
Chinese (279) 279
Italian (260) 260
Polish (194) 194
Portuguese (103) 103
Danish (84) 84
Hungarian (83) 83
Czech (81) 81
Dutch (69) 69
Swedish (62) 62
Norwegian (56) 56
Korean (37) 37
Finnish (30) 30
Slovak (28) 28
Romanian (26) 26
Hebrew (22) 22
Ukrainian (22) 22
Turkish (21) 21
Croatian (17) 17
Serbian (17) 17
Lithuanian (13) 13
Persian (5) 5
Bosnian (4) 4
Bulgarian (4) 4
Slovenian (2) 2
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of the American College of Cardiology, ISSN 0735-1097, 04/2018, Volume 71, Issue 13, pp. 1474 - 1482
Most guidelines for the management of patients with cardiovascular disease recommend angiotensin-converting enzyme (ACE) inhibitors as first-choice therapy,... 
angioedema | blood pressure | heart failure | chronic kidney disease | left ventricular hypertrophy | angiotensin receptor blocker | coronary heart disease | adverse events | cough | diabetes | hypertension | CHRONIC HEART-FAILURE | CARDIAC & CARDIOVASCULAR SYSTEMS | METAANALYSIS | RANDOMIZED-TRIALS | CARDIOVASCULAR EVENTS | VENTRICULAR SYSTOLIC FUNCTION | RECEPTOR BLOCKERS | ANTIHYPERTENSIVE EFFICACY | BLOOD-PRESSURE | ACE-INHIBITORS | HIGH-RISK | Angioedema - epidemiology | Angiotensin II Type 1 Receptor Blockers - adverse effects | Angiotensin II Type 1 Receptor Blockers - therapeutic use | Humans | Hypertension - drug therapy | Renin-Angiotensin System - physiology | Antihypertensive Agents - therapeutic use | Hypertension - physiopathology | Antihypertensive Agents - adverse effects | Animals | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Angiotensin-Converting Enzyme Inhibitors - adverse effects | Cardiovascular Diseases - epidemiology | Angioedema - chemically induced | Renin-Angiotensin System - drug effects | Blood Pressure - drug effects | Blood Pressure - physiology | Cardiovascular Diseases - chemically induced | Clinical Trials as Topic - methods | Hypertension - epidemiology | Drug Therapy, Combination | Angiotensin Receptor Antagonists - therapeutic use | Angiotensin Receptor Antagonists - adverse effects | Heart | Hypertension | Medical colleges | Mortality | Coronary heart disease | Cardiovascular agents | Hospitals | Chronic kidney failure | Analysis | Cardiac patients | Angiotensin | Cardiology | ACE inhibitors | Myocardial infarction | Angiotensin-converting enzyme inhibitors | End-stage renal disease | Enzyme inhibitors | Peptidyl-dipeptidase A | Blood pressure | Drug therapy | Heart diseases | Cerebral infarction | Stroke | Angioedema | Risk analysis | Disease control | Patients | Inhibitors | Renal failure | Infarction | Kidney diseases | Diabetes | Cardiovascular diseases
Journal Article
Journal Article
Journal Article